This federal contract award, valued at $2,010.06, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to The Maclean Group LLC, a small disadvantaged, veteran-owned, and service-disabled veteran-owned business based in Sacramento, California. The contract is for the delivery of Naloxone Hydrochloride, a medication used to reverse opioid overdose. This contract does not have a set-aside designation. The Maclean Group LLC is an experienced federal contractor,...
The U.S. Defense Logistics Agency (DLA) awarded a $2,010.06 firm-fixed-price purchase order contract to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business, for the supply of naloxone hydrochloride, a medication used to reverse opioid overdose. This contract has an ultimate completion date of May 13, 2024. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that holds several...
The U.S. Department of Defense's Medical Supply Chain agency awarded a $1,005.03 firm fixed price purchase order to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business based in Sacramento, California. The award is for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdose, and has a period of performance through March 13, 2025. The Maclean Group, an ISO 9001:2015 certified medical and pharmaceutical...
This is a $2,010.06 firm fixed-price purchase order contract awarded by the Defense Department's Medical Supply Chain agency to The Maclean Group LLC, a small disadvantaged, veteran-owned, and service-disabled veteran-owned business based in Sacramento, California. The contract is for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdoses, with a performance period ending on May 31, 2024. The Maclean Group holds several other significant federal contract...
This federal contract award, with ID SPE2DP25P0303, was issued by the Medical Supply Chain division of the Defense agency to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business based in Sacramento, California. The $24,120.72 firm fixed-price purchase order is for the delivery of naloxone hydrochloride, a critical medication used to reverse opioid overdoses. The Maclean Group is an ISO 9001:2015 certified medical and...
The U.S. Department of Defense's Medical Supply Chain agency awarded a $1,005.03 firm fixed-price purchase order contract to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business based in Sacramento, California. The contract is for the delivery of naloxone hydrochloride, a critical medical supply. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that holds several federal contract...
This is a $11,055.33 firm-fixed-price purchase order awarded by the Defense Logistics Agency (DLA) to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the delivery of 8510615068 ! NALOXONE HYDROCHLORIDE, which is a medical product used to reverse opioid overdose. The award has a total small business set-aside designation and an ultimate completion date of May 21, 2024. The Maclean Group is an ISO...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price purchase order contract worth $2,010.06 to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business, for the supply of naloxone hydrochloride. The contract has a performance period ending on May 13, 2024. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that provides a range of products and services to federal...
This contract was awarded by the Defense Logistics Agency (DLA) to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The $18,090.54 firm fixed-price purchase order is for the delivery of 8510751637 - Naloxone Hydrochloride, a critical medication used to reverse opioid overdoses. The contract has a 100% small business set-aside and is scheduled for completion by July 29, 2024. The Maclean Group is an ISO 9001:2015 certified...
This is a firm fixed price purchase order contract awarded by the Medical Supply Chain, a component of the Department of Defense, to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract, valued at $2,010.06, is for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdose. The contract has a performance period ending on May 10, 2024. The Maclean Group is an ISO 9001:2015 certified...